Search Results - "Youssov, K"

Striatal connectivity in pre‐manifest Huntington’s disease is differentially affected by disease burden by Pini, L., Youssov, K., Sambataro, F., Bachoud‐Levi, A.‐C., Vallesi, A., Jacquemot, C.

“…Background and purpose Different amounts of cumulative exposure to the toxic mutant form of the huntingtin protein might underlie the distinctive pattern of…”
Get full text

Striatal degeneration impairs language learning: evidence from Huntington's disease by De Diego-Balaguer, R., Couette, M., Dolbeau, G., Dürr, A., Youssov, K., Bachoud-Lévi, A.-C.

“…Although the role of the striatum in language processing is still largely unclear, a number of recent proposals have outlined its specific contribution…”
Get full text

Clinical description of the broad range of neurological presentations of COVID-19: A retrospective case series by Cleret de Langavant, L., Petit, A., Nguyen, Q.T.R., Gendre, T., Abdelhedi, J., Djellaoui, A., Seddik, L., Lim, L., Faugeras, F., Salhi, H., Wahab, A., Fechtenbaum, L., Dormeuil, A., Hosseini, H., Youssov, K., Fénelon, G., Bapst, B., Brugières, P., Tuilier, T., Kalsoum, E., Matignon, M.-B., Oniszczuk, J., Gallien, S., Vindrios, W., Melica, G., Scain, A.-L., Esser, R., Rostain, L., Guillaud, C., Dubos-Lascu, G., Saada, N., Guillet, H., Khellaf, M., Bardel, B., Ayache, S.S., Lefaucheur, J.-P., Pawlotsky, J.-M., Fourati, S., Bachoud-Lévi, A.-C.

“…Neurological disorders associated with SARS-CoV-2 infection represent a clinical challenge because they encompass a broad neurological spectrum and may occur…”
Get full text

Guidelines for clinical pharmacological practices in Huntington's disease by Désaméricq, G., Youssov, K., Charles, P., Saleh, N., Olivier, A., Sherer-Gagou, C., Verny, C., Bachoud-Lévi, A.-C.

“…Evidence-based medicine is a difficult goal to achieve in rare diseases where randomized controlled trials are lacking. This report provides guidelines that…”
Get full text

Dystonies et tremblements d’utilisation instrumentale répétitive by Jedynak, C.P., Youssov, K., Apartis, E., Welter, M.-L., Willer, J.-C., Agid, Y.

“…Trois tableaux équivalents regroupant 24 patients qui ont en commun les éléments suivants sont présentés : l’usage excessivement répété d’un instrument qui…”
Get full text

Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis by Radue, Ernst-Wilhelm, Stuart, William H, Calabresi, Peter A, Confavreux, Christian, Galetta, Steven L, Rudick, Richard A, Lublin, Fred D, Weinstock-Guttman, Bianca, Wynn, Daniel R, Fisher, Elizabeth, Papadopoulou, Athina, Lynn, Frances, Panzara, Michael A, Sandrock, Alfred W

“…Abstract The SENTINEL study showed that the addition of natalizumab improved outcomes for patients with relapsing multiple sclerosis (MS) who had experienced…”
Get full text

Huntington Disease Like Phenotypes Not Linked to CAG Repeat Expansions in the HTT Gene (S32.002) by Charles, P., Mariani, L.-L., Cazeneuve, C., Hahn-Barma, V., Youssov, K., Noel, S., Peuvion, J.-N., Seilhean, D., Freeman, L., Roze, E., Bachoud-Levi, A.-C., Durr, A.

“…Abstract only…”
Get full text

C08 Caffeine is a modifier of age at onset in Huntington's disease by Duru, C, Simonin, C, Richard, F, Hincker, P, Génin, M, Charles, P, Youssov, K, Burnouf, S, Azulay, J-P, Verny, C, Tranchant, C, Goizet, C, Defebvre, L, Sablonnière, B, Rousseau, M, Buée, L, Amouyel, P, Godefroy, O, Dürr, A, Bachoud-Lévi, A-C, Blum, D, Krystkowiak, P

“…Background Phenotypic expression is variable in Huntington's disease (HD). Mutation in the IT15/HD1 gene statistically predicts for the age at onset (AAO), but…”
Get full text

L03 Use and impact of neuroleptics in Huntington's disease: a prospective cohort study of the Huntington French speaking group by Dolbeau, G, Lombard, A, Youssov, K, Dürr, A, Charles, P, Verny, C, Azulay, J-P, Krystkowiak, P, Simonin, C, Tranchant, C, Goizet, C, Damier, P, Supiot, F, Broussolle, E, Démonet, J-F, Marie, R-M, Verin, M, Bachoud-Lévi, A-C, Maison, P

“…Background Recent reviews of available drug trials and case reports conclude that the guidelines for the treatment of Huntington's disease (HD) symptoms are…”
Get full text

Experience of an out-patient multidisciplinary approach in disabled patients with multiple sclerosis by Papeix, C, Charles, P, Kopf, A, Youssov, K, Mailhan, L, Assouad, R, Stankoff, B, Lyon-Caen, O, Lubetzki, C

“…Background: In our multiple sclerosis (MS) clinic, we propose to treat disabled patients with an outpatient multidisclplinary approach (OMA) by a team composed…”
Get full text

Dystonia, tremor and repetitive instrumental use by Jedynak, C P, Youssov, K, Apartis, E, Welter, M-L, Willer, J-C, Agid, Y

“…Three characteristic observations are presented along with three tables presenting 24 patients with the following elements in common: excessively repeated use…”
Get full text

Vascularite cutanée révélant une tuberculose pulmonaire au cours d'une infection par le VIH by Dupont, C., Chadenat, M.L., Youssov, K., Blanc, F., Rouveix, E.

Get full text

Réactivation du virus de la varicelle-zona sans lésion cutanéomuqueuse:Méningite avec atteinte de nerfs crâniens by Chadenat, M.L., Youssov, K., Peron, S., Dupont, C., Dorra, M., Rouveix, E.

Get full text

Encéphalopathie à la sulfasalazine by Chadenat, M.L., Youssov, K., Dupont, C., Dechy, H., Raffin Sanson, M.L., Dorra, M., Rouveix, E.

Get full text

Facial palsy relevant to HIV seropositivity by Youssov, K, Wegener, K, Bolgert, F, Pierrot-Deseilligny, C

Get more information